Invenra Signs On With Merck in Antibody Discovery Partnership

18:16 EDT 28 Jul 2017 | Xconomy

Invenra has had success developing therapeutic antibodies for its own drug research, and for the research of others. Now the Madison, WI-based company has signed on with pharma giant Merck, which hopes Invenra’s antibody expertise can help it develop new drugs. Under the terms of the recent agreement, Invenra will discover antibodies against a target […]

Original Article: Invenra Signs On With Merck in Antibody Discovery Partnership


More From BioPortfolio on "Invenra Signs On With Merck in Antibody Discovery Partnership"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...